Spruce Biosciences Files 8-K on Shareholder Vote

TL;DR

SPRB filed an 8-K for a shareholder vote on 5/22. Governance in play.

AI Summary

Spruce Biosciences, Inc. filed an 8-K on May 24, 2024, reporting on a matter submitted to a vote of security holders on May 22, 2024. The filing details the company's principal executive offices located at 611 Gateway Boulevard, Suite 740, South San Francisco, California.

Why It Matters

This filing indicates a formal process involving shareholder decisions, which can impact corporate governance and future strategic directions for Spruce Biosciences.

Risk Assessment

Risk Level: low — The filing is a routine disclosure of a shareholder vote and does not contain information about significant financial changes or operational risks.

Key Players & Entities

• Spruce Biosciences, Inc. (company) — Registrant
• May 22, 2024 (date) — Date of earliest event reported
• May 24, 2024 (date) — Date of report
• 611 Gateway Boulevard, Suite 740, South San Francisco, California 94080 (location) — Principal executive offices

FAQ

Key Financial Figures

• $0.0001 — ch registered Common Stock, par value $0.0001 per share SPRB Nasdaq Global Select

Filing Documents

• sprb-20240522.htm (8-K) — 56KB
• 0000950170-24-064561.txt ( ) — 179KB
• sprb-20240522.xsd (EX-101.SCH) — 31KB
• sprb-20240522_htm.xml (XML) — 5KB

07 Submission of Matters to a Vote of Security Holders

Item 5.07 Submission of Matters to a Vote of Security Holders. On May 22, 2024, Spruce Biosciences, Inc. (the "Company") held its 2024 Annual Meeting of Stockholders (the "Annual Meeting"). As of March 25, 2024, the record date for the Annual Meeting, 41,152,616 shares of common stock were outstanding and entitled to vote at the Annual Meeting. A summary of the matters voted upon by stockholders at the Annual Meeting is set forth below. Proposal 1. Election of Directors The Company's stockholders elected the two persons listed below as Class I Directors, each to serve until the Company's 2027 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified. The final voting results are as follows: Votes For Votes Withheld Broker Non-Votes Tiba Aynechi, Ph.D. 19,761,274 639,508 10,667,525 Kirk Ways, M.D., Ph.D. 19,286,428 1,114,354 10,667,525 Proposal 2. Ratification of the Selection of Independent Registered Public Accounting Firm The Company's stockholders ratified the selection by the Audit Committee of the Company's Board of Directors of BDO USA, LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024. The final voting results are as follows: Votes For Votes Against Abstentions Broker Non-Votes 30,581,608 436,679 50,020 -

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. SPRUCE BIOSCIENCES, INC. Date: May 24, 2024 By: /s/ Samir Gharib Samir Gharib President and Chief Financial Officer

View Full Filing

View this 8-K filing on SEC EDGAR